CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

about

FoxO transcription factors in cancer metabolism.CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer.Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis.

P2860

Q50137602-A1B31651-538F-445F-9842-8854B5775D51 Q52592862-4121EA84-9A28-472F-ABFA-78BF342A972F Q52653079-9C836329-ED73-41EF-A8B9-8E8980686BFF

P2860

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

Item

http://www.wikidata.org/entity/Q38639827

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

@en

type

Item

label

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

@en

prefLabel

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

@en

P1476

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

@en

P2093

Alessandra Dall'Acqua

http://www.w3.org/2001/XMLSchema#string

Delia Mezzanzanica

http://www.w3.org/2001/XMLSchema#string

Gennaro Chiappetta

http://www.w3.org/2001/XMLSchema#string

Giorgio Giorda

http://www.w3.org/2001/XMLSchema#string

Ilenia Pellizzari

http://www.w3.org/2001/XMLSchema#string

Joshua Armenia

http://www.w3.org/2001/XMLSchema#string

Roberto Sorio

http://www.w3.org/2001/XMLSchema#string

Sara Benevol

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Integrated genomic analyses of ovarian carcinoma

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis

Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a

P304

1415-1433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMMM.201607012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28778953

http://www.w3.org/2001/XMLSchema#string

P932

5623833

http://www.w3.org/2001/XMLSchema#string

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

about

P2860

P2860

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932